TRPX
Therapix Biosciences Ltd.
TRPX
TRPX
Delisted
TRPX was delisted on the 1st of July, 2020.
7 hedge funds and large institutions have $312K invested in Therapix Biosciences Ltd. in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$271K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$26K |
| 3 |
3
Millennium Management
New York
|
$9K |
| 4 |
4
Envestnet Asset Management
Chicago,
Illinois
|
$6K |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $271K | +$264K | +424,656 | +3,682% |
|
|
2
UBS Group
Zurich,
Switzerland
| $26K | +$22.6K | +35,962 | +658% |
|
|
3
Millennium Management
New York
| $9K | +$9K | +14,200 | New |
|
|
4
Envestnet Asset Management
Chicago,
Illinois
| $6K | +$6K | +10,018 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$4K | -10,180 | Closed |
|